Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Lancet 2005; 366: 895-906
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002; 359: 995–1003
Should ß-blockers remain first choice in the treatment of primary hypertension? A meta-analysis.
Lancet 2005; 366: 1545–53
Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol Followed by Enalapril,...continua a leggere
Iscriviti gratuitamente e ricevi le news di CardioLink direttamente nella tua e-mail
ABSTRACT SEMPLIFICATO DEI CONTENUTI DI CARDIOLINK SCIENTIFIC NEWS
VISUALIZZA VERSIONE COMPLETA